![(2S)-N-[4-[3-cyano-1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]indol-5-yl]oxyphenyl]pyrrolidine-2-carboxamide in PDB entry 5ajx, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/5ajx_entity_5_side_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>5ajx</span> contains 2 copies of <span class='highlight'>(2S)-N-[4-[3-cyano-1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]indol-5-yl]oxyphenyl]pyrrolidine-2-carboxamide</span>. Side view.")
![(2S)-N-[4-[3-cyano-1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]indol-5-yl]oxyphenyl]pyrrolidine-2-carboxamide in PDB entry 5ajx, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/5ajx_entity_5_top_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>5ajx</span> contains 2 copies of <span class='highlight'>(2S)-N-[4-[3-cyano-1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]indol-5-yl]oxyphenyl]pyrrolidine-2-carboxamide</span>. Top view.")
Environment details NEW
FD9 1448 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.